NCT05996185
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05996185
Title Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tarsheen Sethi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center, Clinical Trials Office RECRUITING New Haven Connecticut 06510 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field